AUM Biosciences Pte Ltd
1 clinical trials · Sponsor
◉ Watch AUM Biosciences Pte Ltd
| Record | Firm | Date |
|---|---|---|
| MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer (NCT05462236) | AUM Biosciences Pte Ltd | 2023-04-14 |
Track AUM Biosciences Pte Ltd automatically
Every clearance here is in the API, with alerts when new ones post.